Hostname: page-component-586b7cd67f-dlnhk Total loading time: 0 Render date: 2024-11-26T15:24:24.963Z Has data issue: false hasContentIssue false

The Most Severe Somatic Disorders Treated with Excitaloprim

Published online by Cambridge University Press:  16 April 2020

S. Kaludjerovic*
Affiliation:
Hospital Dr Lazarevic Laza, Belgrade, Serbia

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Almost all of patients treated for cancers, experience episodes of persistent depression. Which moment is the most terrible? The moment patients hear their diagnosis,or time suffer while getting chemotherapy?

The time on controls tumor markers or when their relatives give up on them? When mirror reflects damaged body and face. Or felt useless in the presence of their children?

  • diagnosis of cancers C00,E05 are difficult to accept, and go hand in hand with major depression F33/ according to ICD-10.

  • why excitaloprim as choice?

Patients age 27 to 37 need antidepressant with pharmacokinetic superiority. Excitaloprim works faster than any other antidepressant, and it is strong, thanks to its dual serotonergic bonding on primar part as well as alosteric part bonding. It is weak inhibitor of the well defined liver cytochrome P450 isoenzym, CYP2D6., EEg .EKG is ok, so its safe drug/.

In this study, I followed the results of excitaloprim treatment on 30 patients (20 females, 10 males).

During 2 months, 20 patients were diagnosed with cancer (mostly colon and breast). All this patients have already been operated. Some have anus praeternaturalis.Other patients have AIDSinitial phase, and autoimmune dg/

On Hamilton scale, 45, points, MADRS on 10 items, 40, on Becks scale 65.Zung self rating index o,6. In this project, patients without children were much more suicidal.

Cancer patients got 20 mg excitaloprim pro die, other 10 mg pro die. After 2 moths

scales showed statistically important improvements despite severity.

Type
P01-116
Copyright
Copyright © European Psychiatric Association 2009
Submit a response

Comments

No Comments have been published for this article.